Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00510744 · ClinicalTrials.gov registry record · NA

Pancreatic Enzymes to Restore Digestive Function in Malnourished Gastric Bypass Patients

A NA study of Obesity, sponsored by University of Pittsburgh.

Completed
Registry status
NA
Development phase
5
Enrollment target
1
Study location

NCT00510744: Completed NA study of Obesity, sponsored by University of Pittsburgh.

NCT00510744 is a NA study of Obesity that has completed, run by University of Pittsburgh. The registered enrollment target is 5 participants, below the 819-participant average among 1,053 other Obesity trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00510744, a NA study of Obesity, has completed, sponsored by University of Pittsburgh.

COMPLETED
Registry status
NA
Development phase
5 participants
Enrollment target
1
Study location

Study Summary

Hypothesis: Bypass of the upper GI tract with bariatric surgery results in suppression of pancreatic function resulting in maldigestion and further malabsorption. In this study we will measure pancreatic secretion in previously obese gastric bypass patients with excessive weight loss. If malabsorption is associated with diminished pancreatic secretion, we will test over a 3 month period whether supplementation with enzyme supplements prevent further weight loss.

Primary Outcome

72 hour fat absorption study

Conditions Studied

Interventions

  • DRUG pancreatic enzyme supplement

Study Locations (1)

Pennsylvania

  • University of Pittsburgh GCRC - Pittsburgh

Trial Details

FieldValue
Enrollment Target 5 participants
Start Date 2007-08
Est. Completion 2015-08
Phase NA
University of Pittsburgh

1,238 total trials

What the finished NCT00510744 record still lists

NCT00510744 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 5 participants, a relatively small participant target, below the 819-participant average among 1,053 other Obesity trials with a reported enrollment target (99% lower).

The record links to 1 condition, with Obesity appearing as the primary indexed condition, and to 1 intervention - of which pancreatic enzyme supplement is the first listed.

NCT00510744 reports a single indexed study location in Pennsylvania.

Frequently Asked Questions

What is clinical trial NCT00510744 about?

NCT00510744 is a clinical study titled "Pancreatic Enzymes to Restore Digestive Function in Malnourished Gastric Bypass Patients". Hypothesis: Bypass of the upper GI tract with bariatric surgery results in suppression of pancreatic function resulting in maldigestion and further malabsorption. In this study we will measure pancreatic secretion in previously obese gastric bypass patients with excessive weight loss. If malabsorpti...

What is the current status of trial NCT00510744?

This trial is currently completed. It is a NA study. The enrollment target is 5 participants. The study started on 2007-08. Estimated completion is 2015-08.

What conditions does trial NCT00510744 study?

This clinical trial studies the following conditions: Obesity.

What interventions are being tested in trial NCT00510744?

The interventions under investigation include: pancreatic enzyme supplement (DRUG).

Who is sponsoring clinical trial NCT00510744?

This trial is sponsored by University of Pittsburgh, which has 1,238 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00510744 being conducted?

This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Obesity

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT00510744's enrollment target sits among peer trials

5 1050th of 1053 higher than 1 of 1,053 other Obesity trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Obesity trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00510744, the US trial registry maintained by the National Library of Medicine. NCT00510744 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.